Results 111 to 120 of about 8,745 (185)

[Perception of family functioning, nutritional status and metabolic control in adolescents with type 1 diabetes mellitus]. [PDF]

Aten Primaria, 2021
Murillo Álvarez N, Rodríguez-Orozco AR.   +1 more
europepmc   +1 more source

[Comprehensive approach to comorbidities in COPD: expert recommendations]. [PDF]

Open Respir Arch
de Miguel-Díez J, Figueira Gonçalves JM, Ji Z, Pascual Guardia S, Represas C.   +4 more
europepmc   +1 more source

Efectos del confinamiento por COVID-19 sobre el control glucémico de niños y adolescentes con diabetes mellitus tipo 1

, 2023
García FH, Velázquez VEG, Figueroa JC, García ERP, Rodríguez EMP.   +4 more
europepmc   +1 more source

Efecto de Liraglutida en Control Glucémico e Índice de Masa Corporal

M Carrasco, Fabiola Méndez Valderrabano, Enrique Torres‐Rasgado, Héctor Santos Mellado, I. Benítez   +4 more
openalex   +2 more sources

Disordered eating behaviors in people with type 1 diabetes mellitus: a scoping review. [PDF]

Rev Esc Enferm USP
Marques SJS, Garces TS, Mattos SM, Damasceno LLV, Araújo AL, Forte RSC, Freire KA, Cestari VRF, Freitas CHA, Moreira TMM.   +9 more
europepmc   +1 more source

Prevalence of diabetes, epidemiological characteristics and vascular complications. [PDF]

Arch Cardiol Mex, 2023
Russo MP, Grande-Ratti MF, Burgos MA, Molaro AA, Bonella MB.   +4 more
europepmc   +1 more source

Risk of imbalanced glycemic pattern: diagnostic content validity. [PDF]

Rev Esc Enferm USP
Gonçalves LM, Lopes ROP, Gomes EDS, Silva TDSE, Cardoso RB, Brandão MAG.   +5 more
europepmc   +1 more source

Hypovitaminosis D in patients with type 2 diabetes: risk factors and association with glycemic control and established microvascular complications [PDF]

Rev Fac Cien Med Univ Nac Cordoba, 2022
Ramírez Stieben LA, Dobry R, Anca L, González A, López MI, Bayo S, Sánchez A, Brance ML.   +7 more
europepmc   +1 more source

Parámetros de variabilidad glucémica de la monitorización continua de glucosa como predictores de diabetes: evaluación prospectiva en una población general sin diabetes. [PDF]

Adv Lab Med
Valle Rodríguez A, Rodríguez García J, Camiña Darriba F, Ortolá Devesa JB, Rodríguez-Segade Villamarín S.   +4 more
europepmc   +1 more source

[Pharmacological treatment of type 2 diabetes mellitus]. [PDF]

Aten Primaria
García Soidán FJ, Riveiro Villanueva J.   +1 more
europepmc   +1 more source